Polo-like Kinase Plk2 Is an Epigenetic Determinant of Chemosensitivity and Clinical Outcomes in Ovarian CancerNelofer Syed, Tim Crook, Eleftheria Hatzimichael et al.|Cancer Research|2011Cited by 60
Heat Shock Protein HSP27 Secretion by Ovarian Cancer Cells Is Linked to Intracellular Expression Levels, Occurs Independently of the Endoplasmic Reticulum Pathway and HSP27’s Phosphorylation Status, and Is Mediated by Exosome LiberationMatthias B. Stope, Alexander Mustea|Disease Markers|2017Cited by 58
Supplementary Figure 3 from Polo-like Kinase Plk2 Is an Epigenetic Determinant of Chemosensitivity and Clinical Outcomes in Ovarian CancerNelofer Syed, Tim Crook, Helen M. Coley et al.|Unknown|2023Cited by 0
Supplementary Table 1 from Polo-like Kinase Plk2 Is an Epigenetic Determinant of Chemosensitivity and Clinical Outcomes in Ovarian CancerNelofer Syed, Tim Crook, Helen M. Coley et al.|Unknown|2023Cited by 0
Supplementary Figure 3 from Polo-like Kinase Plk2 Is an Epigenetic Determinant of Chemosensitivity and Clinical Outcomes in Ovarian CancerNelofer Syed, Tim Crook, Helen M. Coley et al.|Unknown|2023Cited by 0